Abstract
Objectives: Endometrial carcinoma is one of the most common gynecological cancers. It is generally divided into oestrogen-dependent type I, and oestrogen-independent type II. Although the expression of some steroid receptors has been documented in type II endometrial carcinoma, their roles in tumor progression have not been fully elucidated yet. Thus in this study, we aimed to examine the role of compounds acting on steroid receptors in type II, on HEC1A cultured cells.
Methods: We tested the effect of mifepristone (the glucocorticoid and progesterone receptor blocker, 10-8M), bicalutamide (the androgen receptor blocker, 10-6M), G15 (the G-protein-coupled estrogen receptor-1 blocker, 10-7M) and PHTPP (2-Phenyl-3-(4-hydroxyphenyl)-5,7-bis (trifluoromethyl)-pyrazolo [1,5-a]pyrimidine, the estrogen receptor-β blocker, 10-7M), on proliferation. Proliferation was assessed by xCELLigence analysis system and migration was examined by using wound-healing model.
Results: None of the drugs, at the used concentrations, have affected the proliferation of HEC1A cells. However, migration was significantly increased at the 24th and the 48th hour of mifepristone application (p
Publisher
Dicle Medical Journal/Dicle Tip Dergisi
Subject
General Earth and Planetary Sciences,General Engineering,General Environmental Science
Reference35 articles.
1. 1. Bray F, Colombet M, Mery L, et al. Cancer Incidence in Five Continents, Vol. XI. Lyon: IARC Publication;2018.
2. 2.https://gco.iarc.fr/today/home. Source: Globocan 2020 (Turkey) Accessed April 19, 2023.
3. 3.Felix AS, Weissfeld JL, Stone RA, et al. Factorsassociated with Type I and Type II endometrialcancer. Cancer Causes Control. 2010;1(11):1851-6.
4. 4.Setiawan VW, Yang HP, Pike MC, et al. Type I andII Endometrial Cancers: Have They Different RiskFactors? J Clin Oncol. 2013;31(20):2607-18.
5. 5.Gronemeyer H, Gustafsson JÅ, Laudet V. Principles for modulation of the nuclear receptor superfamily.Nat Rev Drug Discov. 2004;3(11):950-64.